Betty Mwesigwa

Kampala, C, Uganda

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa.

Beyond PrEP: The Imperative for an HIV Vaccine to End the Epidemic in Africa.

Journal: Vaccines

Published: May 01, 2026

Patterns and Predictors of HIV Pre-exposure Prophylaxis (PrEP) Continuity Among Young Women Who Sell Sex in Uganda: A Group-Based Trajectory Modeling Approach.

Patterns and Predictors of HIV Pre-exposure Prophylaxis (PrEP) Continuity Among Young Women Who Sell Sex in Uganda: A Group-Based Trajectory Modeling Approach.

Journal: AIDS and behavior

Published: December 07, 2025

COVID-19 knowledge, attitudes, and practices among people vulnerable to HIV in Uganda: A cross-sectional cohort analysis.

COVID-19 knowledge, attitudes, and practices among people vulnerable to HIV in Uganda: A cross-sectional cohort analysis.

Journal: PloS one

Published: October 14, 2025

Finding the Sweet Spot: Preferences for Effectiveness, Duration, and Side Effects in a Discrete Choice Experiment Among Uganda's Key Populations.

Finding the Sweet Spot: Preferences for Effectiveness, Duration, and Side Effects in a Discrete Choice Experiment Among Uganda's Key Populations.

Journal: Vaccines

Published: August 13, 2025

Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filoviruses.

Journal: Science translational medicine

Published: April 02, 2025

Exploring HIV prevention preferences among key populations in Uganda: A qualitative study.

Exploring HIV prevention preferences among key populations in Uganda: A qualitative study.

Journal: PloS one

Published: February 17, 2025

Africa is an Essential Partner in the Research and Development of an HIV Vaccine.

Africa is an Essential Partner in the Research and Development of an HIV Vaccine.

Journal: Current HIV research

Published: October 23, 2024

Sustaining Functionality of Not-for-Profit Health Organisations During Pandemics: Lessons and COVID 19 Experience from Makerere University Walter Reed Project.

Sustaining Functionality of Not-for-Profit Health Organisations During Pandemics: Lessons and COVID 19 Experience from Makerere University Walter Reed Project.

Journal: The East African health research journal

Published: January 01, 2024

Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.

Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 01, 2023

HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.

HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.

Journal: Viruses

Published: September 30, 2023

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

Journal: The Lancet. Infectious diseases

Published: April 04, 2023

Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project.

Developing capacity for implementation and evaluation of vaccine trials in Uganda: Perspective of the Makerere University Walter Reed Project.

Journal: African health sciences

Published: November 02, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026